| Balance sheet (USD) | Q4 2026 ended May 31, 2026 | Q3 2026 ended Feb 28, 2026 | Q2 2026 ended Nov 30, 2025 | Q1 2026 ended Aug 31, 2025 | Q4 2025 ended May 31, 2025 | Q3 2025 ended Feb 28, 2025 | Q2 2025 ended Nov 30, 2024 | Q1 2025 ended Aug 31, 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.31M | 1.34M | 2.54M | 3.05M | 2.40M | 3.06M | 2.37M | 2.82M |
| Receivables | 785.0K | 941.0K | 947.0K | 1.21M | 731.0K | 1.27M | 1.33M | 1.55M |
| Inventory | 1.71M | 1.65M | 1.52M | 1.47M | 1.49M | 1.66M | 1.79M | 1.94M |
| Total current assets | 4.02M | 4.12M | 5.19M | 5.90M | 4.88M | 6.20M | 5.95M | 6.45M |
| Property, plant and equipment | 78.0K | 91.0K | 105.0K | 120.0K | 135.0K | 151.0K | 167.0K | 184.0K |
| Goodwill and intangibles | 209.0K | 231.0K | 219.0K | 223.0K | 228.0K | 234.0K | 236.0K | 207.0K |
| Total assets | 6.76M | 4.88M | 6.03M | 6.85M | 5.95M | 7.38M | 7.27M | 7.87M |
| Accounts payable | 377.0K | 730.0K | 740.0K | 681.0K | 295.0K | 632.0K | 848.0K | 1.09M |
| Total current liabilities | 2.48M | 1.56M | 1.60M | 1.69M | 1.74M | 1.65M | 1.88M | 2.15M |
| Total liabilities | 4.13M | 1.56M | 1.60M | 1.70M | 1.84M | 1.84M | 2.16M | 2.52M |
| Retained earnings | -56.94M | -55.80M | -54.49M | -53.17M | -53.17M | -51.62M | -50.46M | -49.51M |
| Shareholders' equity | 2.63M | 3.32M | 4.43M | 5.16M | 4.11M | 5.53M | 5.11M | 5.35M |
From Biomerica Inc.'s 10-K and 10-Q filings with the SEC. Fourth quarters, and quarters where the company only reported year-to-date totals, are worked out by subtracting the earlier quarters. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read balance sheet or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.